PPG to Unveil Marketplace-Ready Automotive Battery Solutions at AABC Europe
10.1.2020 19:13:00 EET | Business Wire | Press release
PPG (NYSE:PPG) today announced that it will unveil an array of marketplace-ready coatings designed to help enhance electric-vehicle battery performance, durability, safety and cost during the Advanced Automotive Battery Conference (AABC) Europe, Jan. 12-16, 2020, at RheinMain Congress Center in Wiesbaden, Germany. The company also will introduce its latest battery thermal management innovation, PPG CORATHERM™ thermal gap filler, during a technical presentation on Monday, Jan. 13.
The PPG booth (#109) at AABC Europe will feature a broad range of solutions for battery cell and pack applications, including thermal gap fillers, a cathode binder free of N-Methylpyrrolidone (NMP), dielectric and intumescent coatings, pack sealants and adhesives. In addition, Calum Munro, PPG senior scientist, research and technology, automotive original equipment manufacturer (OEM) coatings, will detail the development and validation of PPG Coratherm thermal gap filler. This cost-effective, marketplace-ready thermal management solution offers outstanding performance and low density. It is available in 1K and 2K forms and can be tailored to the unique requirements of each OEM.
PPG will feature its recent success in developing a cost-effective cathode binder that eliminates the use of the solvent NMP. The marketplace-ready binder helps streamline formulation and application processes, reducing mixing times by up to 90%, and contributes to longer battery cycle life. NMP, which is widely used in electrode manufacturing, has been identified as a reproductive hazard by several global regulatory agencies.
“PPG’s participation in AABC Europe will enable us to highlight our expertise in helping customers enhance battery performance, durability and safety while reducing total system cost,” said Munro. “We also partner with customers to ensure successful, high-volume application of our latest battery coatings solutions.”
PPG is enabling electric-vehicle OEMs and battery and component manufacturers to accelerate the development of automotive and commercial vehicle energy storage solutions. The company’s broad-based materials expertise touches virtually every area of lithium-ion battery design and construction, helping PPG customers boost energy density, extend service life, improve safety, increase manufacturing throughput and reduce cost per kilowatt hour.
AABC Europe is one of the world’s leading events for automotive battery technologies, expected to attract more than 1,000 participants representing OEMs, materials suppliers and research organizations.
EDITOR’S NOTE: For more information on PPG coatings for electric-vehicle batteries and other mobility solutions, visit www.ppgautocoatings.com. For more information on AABC Europe, visit www.advancedautobat.com/europe.
PPG: WE PROTECT AND BEAUTIFY THE WORLD™
At PPG (NYSE:PPG), we work every day to develop and deliver the paints, coatings and specialty materials that our customers have trusted for 135 years. Through dedication and creativity, we solve our customers’ biggest challenges, collaborating closely to find the right path forward. With headquarters in Pittsburgh, we operate and innovate in more than 70 countries and reported net sales of $15.4 billion in 2018. We serve customers in construction, consumer products, industrial and transportation markets and aftermarkets. To learn more, visit www.ppg.com.
We protect and beautify the world is a trademark and the PPG Logo is a registered trademark of PPG Industries Ohio, Inc.
CATEGORY: Automotive OEM
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200110005378/en/
Contact information
PPG Media Contacts:
Mike Millar
Automotive OEM Coatings
+1 248-641-2237
millar@ppg.com
Keith Rigby
Automotive OEM Coatings
+1 412-434-1718
KRigby@ppg.com
www.ppg.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom